Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

New peripheral vasodilator from Otsuka profiled at recent meeting

March 31, 1998

Quinoline derivative from Green Cross/Asahi Glass shows promising antihypertensive efficacy

March 31, 1998

Antiarrhythmic Na+/H+ exchange inhibitors prepared by Hoechst

March 31, 1998

ACE inhibitors outshine Ca2+ channel blockers for preventing cardiovascular events in diabetics

March 31, 1998

Phase I study results reported for TP10 in AMI

March 31, 1998

Pharmacological profile of new PDE V inhibitor from Eisai

March 31, 1998

KRH-594 evaluated in animal models of nephropathy, vascular hyperplasia

March 30, 1998

Adenosine derivatives for cardiovascular, lipid disorders

March 30, 1998

Lilly evaluates cardiovascular effects of Evista in RUTH trial

March 27, 1998

Bosentan reduces blood pressure in patients with essential hypertension

March 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...